Grous Beth bought GENB
March 2, 2026 · Form 4 insider transaction
Grous Beth bought 300 shares of Generate Biomedicines, Inc. at $16.00 per share, a transaction worth $4.8K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
300
Price
$16.00
Total value
$4.8K
InsiderGrous Beth
RoleOfficer
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMarch 2, 2026
Filing dateMarch 2, 2026
Shares owned after300
OwnershipIndirect
10b5-1 planNo
AmendedNo